result
result
Ramirez joins Houston Methodist as Chair of Obstetrics and Gynecology
Pedro T. Ramirez, MD, will join Houston Methodist as the Chair of Obstetrics and Gynecology. Ramirez comes to Houston Methodist from the MD Anderson Cancer Center, where he was a Professor and Director of the Minimally Invasive Surgical Research and Education in the Department of Gynecologic Oncology. He is recognized as one of the leading surgeons nationally in the field of fertility preservation in young women with early cervical cancer. Ramirez published a landmark trial that was selected as one of the 12 most influential articles in medicine in 2018 by the New England Journal of Medicine.
Houston Methodist received a $10 million commitment to expand academic medical education in the Woodlands. The program is expected to launch in 2024.
This anonymous philanthropic commitment to fellowships is the largest gift to The Woodlands Hospital, or any of the regional hospitals within the Houston Methodist system, has ever received. This commitment will support the expansion of Houston Methodist’s academic medical program into The Woodlands campus. By creating an academic medical campus housed at a regional hospital where patients can seek specialty care typically only offered in the Texas Medical Center, we’re extending the academic culture and patient offerings in The Woodlands beyond standard clinical care.
It is the first time a TMC institution will offer a sponsored academic medical program specifically at one of its community hospitals, which will include fellowships in cardiovascular disease, orthopedic surgery, pulmonary critical care and sports medicine, among others.
This new program also broadens options for advancing scholarly activity with our faculty and staff who will be part of training these residents and fellows and to bring highly specialized offerings to the north side of Houston.
Houston Methodist’s academic medical program includes more than 350 residents and fellows, receiving training in various specialties. While many of these physicians-in-training often rotate to one of Houston Methodist’s eight hospitals in the Greater Houston area, those that are a part of the new academic program will match and serve their full-time residency training in internal medicine, and potentially their fellowship training, in The Woodlands.
Many thanks to the GME team for their hard work in planning out this program.
Digital Methodology
Mylonakis moves Houston Methodist to the front lines of the battle with infectious disease
Just prior to removing COVID-19’s global emergency status, the World Health Organization issued a call to action, a warning against complacency regarding infectious diseases. With the addition of exemplary infectious disease experts to our ranks — including Eleftherios Mylonakis, MD, PhD, the recently recruited chair of the department of medicine — Houston Methodist is moving to the front lines of emerging infectious disease research. Read more in digital Methodology.
NCATS CTSA Webinar: Non-dilutive funding opportunities for research entrepreneurs
Eva Garland Consulting’s Xiaohu (Tiger) Xie, PhD, who has expertise in preparing NIH SBIR/STTR application,s will give a talk titled “Application Tips & Resources to Help Secure SBIR & STTR Funding” from noon to 1 p.m. on June 26. An exclusive SBIR/STTR Bioscience Company Showcase will provide application experience along with tips and recommendations to future applicants.
Click here to learn more.
Research Administration Demonstration Series
The next Research Administration Demonstration Series (RAD) Session, "Using Data to Support Strategic and Operational Decision Making in Research Administration”, will be presented by Jeremy Forsberg and Nina Gray on July 14, from 11 a.m to 12:30 p.m. Please RSVP for any RAD sessions via the online registration.
REI grant funds research at the Center for Health and Nature
The Center for Health and Nature — a collaboration between Texas A&M Health, Houston Methodist, and Texan by Nature — has received a grant from the REI Cooperative Action Fund, which support groups that promote getting out in nature and provides seed money to encourage scientific research.
The center will use the funds to create a statewide health and nature collaborative to connect researchers, practitioners, landowners and conservationists during the next two years. These funds will extend the center’s efforts to study the healing power of nature and encourage people to go outdoors.
Praying for each other
Every week, the Prayer Connect Team at Houston Methodist Hospital sends an email with prayer requests. About 160 Methodist employees have committed to pray for requests from our colleagues and community.
We believe that staying connected is vital to our well-being, so please consider joining the chaplains in this initiative. If you would like to join us in praying for the requests of our employees and community, please reply to this email or contact Michela deTranaltes, Project Specialist for Grace Ministries, so we can add you to our confidential online community.
If you would like to submit a prayer, either text PRAYER to 45991 or email HMHPrayerRequest@houstonmethodist.org.
Mouaz Al-Mallah, MD, Beverly B. and Daniel C. Arnold Distinguished Chair and Professor of Cardiology, has been named President of the American Society of Nuclear Cardiology.
R. Mark Ghobrial, MD, PhD, J.C. Walter Jr. Presidential Distinguished Chair;
Director, J.C. Walter Jr. Transplant Center; Professor of Surgery, has been named President-elect of the International Liver Transplantation Society.
Jun Li, MD, PhD, John M. O’Quinn Foundation Presidential Distinguished Chair in Neurology, Stanley H. Appel Department of Neurology; Chair and Professor of Neurology, has been named Associate Editor for Annals of Clinical and Translational Neurology.
Alan Lumsden, MD, Walter W. Fondren III Presidential Distinguished Chair of the DeBakey, Heart & Vascular Center; Chair and Professor of the Department of Cardiovascular Surgery, has been named President-elect of the Southern Association for Vascular Surgery.
Sankar Mitra, PhD, Professor Emeritus of Medicine, is the recipient of the 2023 Environmental Mutagenesis and Genomics Society Award.
John Cooke, MD, PhD, has founded The Society for RNA Therapeutics (SRT). The SRT is a global network designed to support translational research and development of RNA therapeutics, develop standards for RNA manufacturing, guidelines for clinical trials, clinical best practices in RNA therapeutics, develop training guidelines and provide public and professional education, facilitate public-private-regulatory partnerships, advocate for patients with diseases amenable to RNA therapies, especially for low- and middle-income countries and support early career and professional development.
NIH News
NINDS R35 Research Program Award accepting applications
The NINDS R35 Research Program Award is now accepting applications through July 13.
The goal of this program is to help investigators make meaningful contributions to neuroscience by providing greater funding stability, flexibility, and support for their overall research program and lab.
How does the R35 support their research?
The R35 RPA provides a stable budget based on an investigator’s previous 4-year average (up to $750,000 per year) direct costs, for eight years. This allows neuroscientists to:
Spend less time applying for funding and more time on other professional priorities, such as mentoring junior scientists;
- Make meaningful contributions to neuroscience;
- Conduct research that may require more time;
- Explore novel research questions, methods, or designs; and
- Pivot to emerging and timely topics as they arise.
- They are a Principal Investigator who has received consecutive funding in the past five years (FY19-23) from the following NINDS grants: R00, R01, RF1, R37, R56, DP1, DP2, and current R35 awardees entering their 7th year
- They are conducting research within NINDS mission.
Kenny Lin, MD, contributed to a Forbes Health article on various types of earaches and remedies.
Cardiology fellow Safi U. Khan, MD, was quoted in an American Heart Association press release on the WHO declaring the end of the COVID-19 pandemic. In the release, Khan and other medical experts urge the public to remember the lessons learned from the pandemic including the importance of vaccination. According to Khan, it’s all about balancing normalcy and safety. The release was picked up by Houston Chronicle, NPR, and U.S. News and World Report, among others.
Anaum Maqsood, MD, was interviewed on a new blood test that can detect early colorectal cancer and pre-cancerous growth called Signal-C. The story is published on Yahoo! Life and Verywell Health.
The New York Times homepage includes a special-project story with interactive images on the long-term effects of COVID-19. Reporter Pam Belluck and a graphics/multimedia team collaborated with Siemens to report on the prevalence and presentation of post-COVID lung damage. This five-month-long collaboration with the NYT team explains the various stages of disease and recovery in two patients of Howard J. Huang, MD. John Nance, MD, also shared his time and expertise to decipher some of these scans. The story is now online.
Cesar Arias, MD, PhD, was interviewed by the Huffington Post for a story on human metapneumovirus which the CDC says is more prevalent this year than in the past.
Celebrating Pride Month
On June 22, the LGBTQ+Allies ERG celebrated Annual Pride Celebration with music, activities, snacks and more.
DEI Learning Sessions for Leaders Available
The DEI Learning Team is offering virtual Managing Unconscious Bias sessions for leaders through the month of June. The engaging learning sessions will provide leaders with the tools and skills to assist in recognizing and articulating various types of unconscious bias and begin to mitigate them to help build stronger teams. To register, log into the LMS and search 1638003.
New DEI Learning Email Address
Be on the lookout for messages in your Outlook inbox regarding DEI Learnings, including Managing Unconscious Bias, Recognizing the Impact of Microaggressions, Navigating Multi-Generational Teams and Together We Grow sessions, from the DEILearning@Houstonmethodist.org email address. This new address replaces DEITraining@houstonmethodist.org and is used to communicate information on in-person, campus-specific learning sessions, new DEI resources and more. Questions for the DEI Learning Team should also be sent to this email box.
Enjoy Your DEI Personal Day
The summer vacation season is right around the corner and it’s a great time to use your 2023 DEI Personal Day PTO hours. Eligible employees may use their DEI PTO hours to celebrate days that are special to them or other members of their faith, race, nationality or anything else that makes them unique. Note that unlike standard PTO, the hours do not roll over to the next year, so don’t forget to use your personal day before the last day of the final pay period of 2023, which is Dec. 16. For more details, see HR Policy 72.
We would love to see how you spend your DEI Personal Day this year so we can share with your colleagues in upcoming editions of the DEI Corner. Please forward photos of you enjoying your DEI Personal Day to theofficeofdei@houstonmethodist.org.
Employee Resource Groups Are Booming
Membership in the 10 HM employee resource groups (ERGs) is growing rapidly. Why? They’re an informal and relaxed way to meet up with colleagues who share common interests or backgrounds or want to learn more about the cultural traditions of their co-workers.
The voluntary employee-created and led groups provide a safe, neutral space for employees to discuss unique issues or challenges and professional development opportunities. Members may also participate in networking events and community involvement activities.
Employees across the system can join any ERG they identify with or would like to learn more about and support. You can also start a new group!
To find out what all the excitement is about, text “ERG” to 45991, or contact Nazia Imrose at nimrose2@houstonmethodist.org.
June Cultural Heritage Observances
Caribbean Heritage Month
Pride Month
Juneteenth
Eid al Adha
Job Postings
We have several job openings in the Academic Institute. Click here to find one that interests you, or if you know of someone who might be interested.
We welcome these new employees who joined the Academic Institute in December 2022.
- Jessica Alonso, Education – CNREP, Patient Care Asst Student
- Armando Amador, Infect Disease – Kumaraswami, Research Assistant I
- Jessica Antel, Education – CNREP, RN PRN 1
- Anushka Anand, Cancer Clinical Trials, Research Coordinator I
- Wilbert Biadang, Education – CNREP, RN PRN 1
- Brian Butuyan, Education – CNREP, RN PRN 1
- Mario Castillo, Academic Affairs, Sr Business Analyst
- Kim Cuong Cap, Cancer – Christoforos Thomas, Postdoctoral Fellow 1
- Jonathon Corral, Infectious Disease – Gollihar, Research Assistant I
- Angela Dawson, Cancer Clinical Trials, Research Coordinator I
- Daisy Delgado, Neurosurg – HMW, Research Technician I
- Aatin Dhanda, ENT – Takashima, Research Coordinator I
- Valerie Dietz, Neurosurg – Sayenko, Postdoctoral Fellow 0
- Sidney DiPuma, Education – CNREP, Student Professional Nurse
- Elizabeth Dolan, Education – CNREP, Patient Care Asst Student
- Sara Donovan, Education - CNREP, Student Professional Nurse
- Latavia Edgar, Education – CNREP, Patient Care Asst Student
- Olawunmi Onile-Ere, Education - CNREP, Student Professional Nurse
- Jocelyn Diaz Figuerora, Education - CNREP, Student Professional Nurse
- Katherine Flathom, Education – CNREP, Student Professional Nurse
- Valerie Flores, Neurology – Ashizawa, Research Coordinator III
- Nubici Fosi, MRI Core Laboratory, Clinical Research Nurse
- Nazaret Gamuz-Ruiz, Neurology – Faridar, Postdoctoral Fellow 1
- Isabel Garza, Education – CNREP, Patient Care Asst Student
- Marta Halasa, Transplant - Xian Li, Postdoctoral Fellow 1
- Jose Hernandez, External Relations, Videographr/Photographr/Editor
- Maddalena Horner, Neurosurg – Villapol, Research Technician I
- Siqi Hu, Urology – Satkunasivam, Clinical Rsch Fellow 1
- Rui Jing, Cancer - Yong Lu, Postdoctoral Fellow 0
- Thinh Le, Cancer Clinical Trials, Research Coordinator I
- Lorraine Limon, Education – CNREP, Patient Care Asst Student
- Sidney Little, Education - CNREP, Student Professional Nurse
- Braelyn Lugo, Education – CNREP, Patient Care Asst Student
- Hannah Lux, Education - CNREP, Student Professional Nurse
- Yoo-shin Kim, Nanomedicine – Godin, Research Associate II
- Megan King, Education – CNREP, Patient Care Asst Student
- Alyssa Knowles, Education - CNREP, Student Professional Nurse
- Moonsoo Jin, Radiology Rsrch-Diego Martin, Scientist
- Wanda Quezada, HRPO-IRB, Dir Rsch Regulatory Oversight
- Reshma Madhu, Education – CNREP, RN PRN 1
- Gisselle Martinez, Education – CNREP, Patient Care Asst Student
- Melissa McHann, Radiology Rsrch-Zhonglin Lui, Postdoctoral Fellow 0
- Irene Min, Pre-Clinical Imaging, Research Scientist
- Tatiana Molden, RNA Therapeutics – McRae, Postdoctoral Fellow 0
- Krystal Nolasco, Education – CNREP, Patient Care Asst Student
- Cicley Norris, Education – CNREP, Student Professional Nurse
- Danika Nottage, Transplant – Admin, Research Coordinator I
- Chinyem Nwabudike, AOCT Operations – Baytown, Research Coordinator I
- Jasmine Oakley, TAMU HSC Partnership, Administrative Assistant
- Folake Ogunfayo, Education - CNREP, Student Professional Nurse
- Doris Onyekwere, Transplant – Admin, Clinical Research Nurse
- Evany Orellana, Education – CNREP, Patient Care Asst Student
- Konstantinos Ouranos, Medicine – Mylonakis, Research Associate I
- Megan Owens, Education - CNREP, Student Professional Nurse
- Josephine Panamkalayil, Education – CNREP, RN PRN 1
- Erin Park, HR-General, Sr Recruiter
- Joanne Park, Faculty & Institutional Dev, Graphic Designer
- Dulce Pichardo, Education – CNREP, Patient Care Asst Student
- Ankita Rao, RNA Therapeutics – Brannan, Research Assistant I
- Mary Reidy, Education - CNREP, Student Professional Nurse
- Isabell Reyes, Education – CNREP, Patient Care Asst Student
- Victor Rivas, Education – CNREP, Patient Care Asst Student
- Whitney Roth, Education - CNREP, Student Professional Nurse
- Subhasree Saha, Infect Disease – Kumaraswami, Postdoctoral Fellow 0
- Sahar Samimi, Structural Heart Dis_Interv, Postdoctoral Fellow 0
- Diana Salgado, Education – CNREP, Patient Care Asst Student
- Alessandro Sammarco, Urologu – Chan, Postdoctoral Fellow 4
- Chotiwat Seephetdee, RNA Therapeutics – Kiss, Postdoctoral Fellow 0
- Meredith Siebers, Education – CNREP, Student Professional Nurse
- Jessica Sims, Education - CNREP, Student Professional Nurse
- Kinsey Slate, HR General, Senior Human Resource Representative
- Nftalem Tekie, Education - CNREP, Student Professional Nurse
- Tabitha Teske, Education – CNREP, Patient Care Asst Student
- Cindy Mendoza Tudares, Education - CNREP, Student Professional Nurse
- Isaac Villatoro, Education – CNREP, Patient Care Asst Student
- Jung Yang, Surgery – Waterman, Student Intern
- Natalie Yokley, Education - CNREP, Student Professional Nurse
- Amileon Williams, Education - CNREP, Student Professional Nurse
- Giulia Zaffaroni, Orthopedics – Taraballi, Research Assistant
- Xiangyu Zhang, RNA Therapeutics – Admin, Financial Analyst
Policy Reminders
BP in Practice is an educational reminder designed to raise awareness regarding Business Practices hot topics, relevant laws and policies & procedures. Find archives of BP in Practice here. If you have questions, contact the BP EthicsLine at 800.500.0333 or visit tmhs.myethicsline.com.
Adjuvant immunotherapy in renal cell carcinoma: a systematic review and meta-analysis
Riveros, C., Huang, E., Ranganathan, S., Klaassen, Z., Rini, B., Wallis, C. J. D., & Satkunasivam, R. (2023). Adjuvant immunotherapy in renal cell carcinoma: a systematic review and meta-analysis. BJU International, 131(5), 553-561. https://doi.org/10.1111/bju.15981
Artificial intelligence in nuclear cardiology: your crucial role in transforming potential into reality
Al-Mallah, M. H. (2023). Artificial intelligence in nuclear cardiology: your crucial role in transforming potential into reality. Journal of Nuclear Cardiology. https://doi.org/10.1007/s12350-023-03276-6
A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery
Naidu, G. S., Yong, S. B., Ramishetti, S., Rampado, R., Sharma, P., Ezra, A., Goldsmith, M., Hazan-Halevy, I., Chatterjee, S., Aitha, A., & Peer, D. (Accepted/In press). A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery. Advanced Science. https://doi.org/10.1002/advs.202301929
Acute Exposure to Pyridostigmine Bromide Disrupts Cholinergic Myenteric Neuroimmune Function in Mice
Collier, C. A., Foncerrada, S., Clevenger, A. J., Shetty, A., & Raghavan, S. A. (Accepted/In press). Acute Exposure to Pyridostigmine Bromide Disrupts Cholinergic Myenteric Neuroimmune Function in Mice. Advanced Biology. https://doi.org/10.1002/adbi.202200254
A Call for More Studies Evaluating Posttraumatic Knee Osteoarthritis in Patients Undergoing Combined Anterior Cruciate Ligament Reconstruction and Lateral Extra-Articular Stabilization
Kraeutler, M. J., & McCulloch, P. C. (2023). A Call for More Studies Evaluating Posttraumatic Knee Osteoarthritis in Patients Undergoing Combined Anterior Cruciate Ligament Reconstruction and Lateral Extra-Articular Stabilization. Arthroscopy - Journal of Arthroscopic and Related Surgery, 39(4), 908-910. https://doi.org/10.1016/j.arthro.2022.12.031
If you have a featured publication, for example on a journal cover, please let us know so we can include it in our next issue.
Bridge to Translational Research Initiative (B2TRI) Request for Applications
The Houston Methodist Academic Institute (HMAI) is pleased to reissue the Bridge to Translational Research Initiative (B2TRI) Request for Applications, which provides funding for promising and clinically relevant research (molecular, cellular, or early pre-clinical research) to advance for TRI funding consideration. The TRI is a Houston Methodist (HM) program designed to identify and fund the further development of drugs, diagnostics, devices, tools or technology that will comprise HM intellectual property. However, some promising ideas are not yet eligible for TRI funding, and the B2TRI program aims to support investigators in preparing these ideas for future competitive TRI applications.
Key Dates
Applications Due: Rolling
Applications must be submitted via the Houston Methodist Intramural Awards portal and will be accepted on a rolling basis. Email submissions will not be accepted.
Link to B2TRI opportunity details page is here.
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation Call for Pre-Applications
Houston Methodist has been invited to nominate one candidate for the Fall 2023 Kleberg Foundation Grant. The Kleberg Foundation supports “highly innovative and groundbreaking medical research proposals from top tier institutions in both basic biological and applied research that will have the greatest impact on scientific knowledge and human health. Proposals should be distinctive and novel in their approaches, question the prevailing paradigm, and lead to advancement of knowledge in the field.”
A selection committee will evaluate and recommend the most suitable application to represent Houston Methodist and formally apply for the Fall 2023 Kleberg Foundation Grant.
Key Dates
Applications Due: June 30, 2023, noon
Applications Reviewed: July 2023
Candidate Selection: August 2023
Houston Methodist has been invited to nominate one candidate for the Fall 2023 Kleberg Foundation Grant. The Kleberg Foundation supports “highly innovative and groundbreaking medical research proposals from top tier institutions in both basic biological and applied research that will have the greatest impact on scientific knowledge and human health. Proposals should be distinctive and novel in their approaches, question the prevailing paradigm, and lead to advancement of knowledge in the field.”
A selection committee will evaluate and recommend the most suitable application to represent Houston Methodist and formally apply for the Fall 2023 Kleberg Foundation Grant.
George and Angelina Kostas Research Center for Cardiovascular Nanomedicine
Request for Applications
The Kostas family continues to generously support Houston Methodist investigators who are working toward high-impact solutions that apply nanomedicine approaches to diagnose and treat cardiovascular diseases.
This Request for Applications seeks research projects in the field of Cardiovascular Nanomedicine. Applications may address any challenge in cardiovascular care that employs nanomedicine technologies, such as the development and application of diagnostics, delivery systems, therapeutics, novel devices, and imaging. Research projects should include significant and immediate nanomedicine applications within the funding period. This funding is not intended to support exploration into biological pathways or mechanisms.
Key Dates
Submission Deadline: July 20 at noon
Committee Review: August - September
Award Announcement: October
Estimated Funding Start Date: Jan. 1
Direct Link to funding opportunity: https://intramural-awards.houstonmethodist.org/#competitionDetail/1902844
Houston Methodist Neal Cancer Center Investigator-Initiated Interventional Treatment Clinical Trial Request for Applications
Key Dates
RFA Release Date: April 25, 2023
Submission Deadline: July 31, 2023
Funding Start Date: September 1, 2023
Funding Opportunity Overview
The goal of this Request for Applications (RFA) is to provide developmental funds for the initiation of innovative Investigator-Initiated Interventional Treatment Trials (IITs), leading to further peer- reviewed funding and high-impact publications.
Eligibility Information
Any Houston Methodist Neal Cancer Center Clinical Member is eligible to apply as PI; Investigators that have demonstrated previous application of scientific discoveries or novel therapeutic combinations and applications through the development of an interventional treatment clinical trial are encouraged to apply.
IIT Awards are funded by the Houston Methodist Neal Cancer Center; the following strategic initiatives will be considered:
- Investigator-initiated clinical research derived from in-house scientific discoveries (including support for correlative science)
- Only Interventional Treatment Trials, as defined by Cancer Center Support Grant criteria, will be considered
- Projects that aim to achieve Cancer Center strategic objectives and focus on one or both of the following criteria:
- Cancers that have high incidence and/or mortality rates within the Houston Methodist Neal Cancer Center Catchment Area (including, breast, prostate, lung, liver, gynecologic, and hematologic malignancies)
- Cancers with a disparate outcome due to social and racial demographics within the catchment area.
Houston Methodist Academic Institute RNA Therapeutics for Cancer Initiative Request for Applications
This Request for Applications (RFA) solicits research projects which focus on personalized RNA cancer vaccines. Applications may include a variety of projects, including 1.) Acquisition of cancer tissue from well-characterized patients for its characterization by RNAseq for discovery of neoantigens; 2.) development and testing of algorithms to define the most immunogenic neoantigens from RNAseq data to design RNA vaccines; 3.) pre-clinical testing of the RNA vaccine in cell culture for assessment of expression and cellular localization, and in animal models for assessment of immune response; 4.) development and testing of immunoassays to assess the immunogenicity of a cancer vaccine. The purpose of this RFA is to prepare the investigators for grant submissions, such as ARPA-H, that will contribute to the development of a personalized RNA Cancer vaccine at HMH.
Key Dates
Submission Deadline: Aug. 9 at noon
Committee Review: August
Award Announcement: August
Funding Award Period: Sept. 1– Aug. 31, 2024
For additional details and eligibility information, please review the attached RFA. Applications must be received by noon on Aug. 9, via the Houston Methodist Intramural Awards Portal (https://intramural-awards.houstonmethodist.org/).
2023 Men of Distinction Annual Award Request for Applications
Key Dates
Internal Application Submission Deadline: August 10, 2023; noon
HMH Foundation Review: August – September 2023
Application Due to Men of Distinction: October 12, 2023
The Men of Distinction funding opportunity provides support for clinician/research scientist partnerships leading pediatric research, education, and/or patient care programs in the Texas Medical Center or Houston area.
Eligibility
- Any Houston Methodist-employed faculty with a primary HMAI academic appointment is eligible to apply as a Principal Investigator (PI).
- Proposals must include a HM-employed Physician and a HM-employed Research Scientist.
- HM-employed, non-independent researchers (e.g., research scientists, research associates, and instructors) are eligible to apply as a co-Investigator (co-I).
- Proposed programs must focus on research, treatment, education, or patient care for children in the Texas Medical Center and the city of Houston.
Houston Methodist Neal Cancer Center Investigator-Initiated CAR-T Cell Treatment Clinical Trial Request for Applications
Key Dates
RFA Release Date: June 6
Submission Deadline: Aug. 31
Funding Start Date: Oct. 1
Funding Opportunity Overview
The goal of this Request for Applications (RFA) is to provide funds for the development of innovative Investigator-Initiated Interventional Chimeric Antigen Receptor (CAR) T Cell Therapy Treatment Trials (IIT), leading to the advancement of the future clinical therapies that may be utilized by patients with a diagnosis of a malignant neoplasm.
IITs are in-house clinical research studies authored or co-authored by Cancer Center investigators that undergo scientific peer review by the center’s Protocol Review and Monitoring System (PRMS). The investigator has the primary responsibility for conceptualizing, designing, implementing, and reporting results of the clinical research study. Proposals are due by Aug. 31.
Applications must be received via electronic submission to CancerCenterBasicScience@houstonmethodist.org by 5 p.m. on the submission deadline
Contact Information: Questions related to the RFA may be sent to CancerCenterBasicScience@houstonmethodist.org
CPRIT Academic Research Program Releases Cycle 24.1 Recruitment RFAs
CPRIT announces the release of three Recruitment RFAs for the Academic Research program. Complete RFAs and instructions detailing applicable deadlines and requirements are available in the Apply for Funding section of CPRIT’s website.
- Recruitment of Established Investigators
- Recruitment of Rising Stars
- Recruitment of First-Time, Tenure-Track-Faculty Members
Browse previous issues
Contact us at news@houstonmethodist.org
Subscribe to this internal e-newsletter here.
Houston Methodist Academic Institute
6670 Bertner Avenue, Houston, TX 77030
Copyright © 2023 Houston Methodist Academic Institute, All rights reserved.